Special Situations, Content Strategist, Smartkarma

Crispin Francis

Special Situations, Content Strategist

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Event-Driven

China Nepstar Chain Drugstore / Event-Driven

This is a quick update on <a href="https://www.smartkarma.com/profiles/13" target="_blank" data-smartkarma-citation="accounts:13">Kemp Dolliver's</a> previous insight "<a href="https://www.smartkarma.com/insights/d4903121-73ad-4c04-9709-f47538533949" target="_blank" data-smartkarma-citation="insights:1023">Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder</a>."<h2>Latest News</h2><blockquote>
SHENZHEN, China, March 16, 2016 /PRNewswire/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, announced today that it has entered into a definitive Agreement and Plan of Merger (the "Merger Agreement") with China…
</blockquote>

This is a quick update on Kemp Dolliver's previous insight "Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder."Latest News
SHENZHEN, China, March 16, 2016 /PRNewswire/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), a leading retail drugstore chain in China based on the number of directly operated stores, announced today that it has entered into a definitive Agreement and Plan of Merger (the "Merger Agreement") with China…


Founder

Kemp Dolliver, CFA

Cherrystone Hill Research

Equity Bottom-Up

IKang Healthcare Group (ADR) / Equity Bottom-Up

iKang Healthcare Group, China's largest private preventive healthcare services provider, has received a preliminary proposal from its founder, chairman/CEO and PE firm FountainVest to take the company private for $US17.80 in cash per ADS. The offer is a modest premium to recent depressed trading levels, and looks ripe for some improvement.

iKang Healthcare Group, China's largest private preventive healthcare services provider, has received a preliminary proposal from its founder, chairman/CEO and PE firm FountainVest to take the company private for $US17.80 in cash per ADS. The offer is a modest premium to recent depressed trading levels, and looks ripe for some improvement.

United States

China Nepstar Chain Drugstore Limited owns and operates a retail drug store chain. The Company has locations throughout China.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

China Nepstar Chain Drugstore (NPD US)

Just What the Doctor Ordered

This is a quick update on Kemp Dolliver's previous insight "Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling...

Crispin Francis

A Buyout Offer That Needs Improvement

iKang Healthcare Group, China's largest private preventive healthcare services provider, has received a preliminary proposal from its founder,...

Kemp Dolliver, CFA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)